Free Trial

Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume

Relmada Therapeutics logo
$0.64 +0.02 (+3.97%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.61 -0.03 (-4.13%)
As of 05/23/2025 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Relmada Therapeutics Short Interest Data

Relmada Therapeutics (RLMD) has a short interest of 2.03 million shares. This marks a 43.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 931,280 shares to cover all short positions.

Current Short Interest
2,030,000 shares
Previous Short Interest
1,410,000 shares
Change Vs. Previous Month
+43.97%
Dollar Volume Sold Short
$654,472.00
Short Interest Ratio
1.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
33,192,000 shares
Percentage of Shares Shorted
6.12%
Today's Trading Volume
742,653 shares
Average Trading Volume
931,280 shares
Today's Volume Vs. Average
80%
Short Selling Relmada Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RLMD Short Interest Over Time

RLMD Days to Cover Over Time

RLMD Percentage of Float Shorted Over Time

Relmada Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20252,030,000 shares $654,472.00 +44.0%N/A1 $0.32
4/15/20251,410,000 shares $434,280.00 -13.0%5.7%0.8 $0.31
3/31/20251,620,000 shares $437,400.00 +8.7%6.5%1.7 $0.27
3/15/20251,490,000 shares $436,123.00 +18.3%6.0%1.4 $0.29
2/28/20251,260,000 shares $327,600.00 -28.0%5.1%0.8 $0.26
2/15/20251,750,000 shares $582,575.00 +108.8%7.1%1.1 $0.33
1/31/2025838,000 shares $292,462.00 -33.0%N/A0.6 $0.35
1/15/20251,250,000 shares $495,625.00 -24.2%N/A1.3 $0.40
12/31/20241,650,000 shares $858,000.00 -7.3%N/A1.7 $0.52
12/15/20241,780,000 shares $653,260.00 +67.9%N/A2.3 $0.37
11/30/20241,060,000 shares $3.20 million -7.8%N/A1.6 $3.02
11/15/20241,150,000 shares $3.46 million -3.4%N/A6.1 $3.01
10/31/20241,190,000 shares $4.14 million -5.6%N/A6.7 $3.48
10/15/20241,260,000 shares $4.38 million +0.8%N/A6.9 $3.48
9/30/20241,250,000 shares $4.05 million +5.9%N/A6.6 $3.24
9/15/20241,180,000 shares $3.65 million -2.5%N/A6.6 $3.09
8/31/20241,210,000 shares $3.39 million -6.2%N/A10.8 $2.80
8/15/20241,290,000 shares $3.32 million -3.0%N/A11.5 $2.57
7/31/20241,330,000 shares $4.87 million -2.2%N/A12.2 $3.66
7/15/20241,360,000 shares $5.22 million +34.7%N/A13.1 $3.84
6/30/20241,010,000 shares $3.03 million -34.8%N/A9.6 $3.00
6/15/20241,550,000 shares $4.67 million +0.7%N/A14.9 $3.01
5/31/20241,540,000 shares $4.62 million -1.9%N/A11.1 $3.00
5/15/20241,570,000 shares $5.46 million -4.3%N/A10.6 $3.48
4/30/20241,640,000 shares $5.97 million -4.1%N/A9.4 $3.64
4/15/20241,710,000 shares $7.61 million +1.2%N/A8.1 $4.45
3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65
3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42
2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13
2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27
1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93
1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14
12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14
12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48
11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47
11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03
10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99
10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10
9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00
9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09
We’ve Entered the Most Bullish Phase of the Cycle (Ad)

It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.

The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin
8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38
8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41
7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62
7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84
6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46
6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55
5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84
5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09
4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52
4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71
3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26
3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56
2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60
2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71
1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06
1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12
12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49
12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14
11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65
11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89
10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39
10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20
9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02
9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39
8/31/20223,250,000 shares $94.71 million +3.2%N/A11.9 $29.14
8/15/20223,150,000 shares $91.79 million +1.0%N/A12.3 $29.14
7/31/20223,120,000 shares $79.87 million +1.0%N/A12.1 $25.60
7/15/20223,090,000 shares $69.43 million -4.9%N/A11.7 $22.47
6/30/20223,250,000 shares $61.72 million +21.7%N/A12 $18.99
6/15/20222,670,000 shares $44.59 million +1.1%N/A9.5 $16.70
5/31/20222,640,000 shares $49.61 million +21.1%N/A9.2 $18.79
5/15/20222,180,000 shares $43.16 million +32.9%N/A6.6 $19.80
4/30/20221,640,000 shares $41.18 million -4.7%N/A5.1 $25.11
4/15/20221,720,000 shares $44.77 million -4.4%N/A5.5 $26.03
3/31/20221,800,000 shares $48.58 million +23.3%N/A5.9 $26.99
3/15/20221,460,000 shares $32.49 million -11.0%N/A5.2 $22.25
2/28/20221,640,000 shares $33.64 million +34.4%N/A5.9 $20.51
2/15/20221,220,000 shares $24.40 million -8.3%N/A5.1 $20.00
1/31/20221,330,000 shares $24.46 million -21.3%N/A6.6 $18.39
1/15/20221,690,000 shares $33.56 million +24.3%10.7%10 $19.86
12/31/20211,360,000 shares $30.64 million +40.7%8.6%8.6 $22.53
12/15/2021966,900 shares $19.51 million +7.7%6.1%7.1 $20.18
11/30/2021897,600 shares $16.03 million +2.9%5.7%8.2 $17.86
11/15/2021872,400 shares $19.79 million -2.8%5.5%9.2 $22.69
10/29/2021897,500 shares $21.06 million -5.9%5.7%8.2 $23.47
10/15/2021953,300 shares $22.53 million -4.3%6.1%4.1 $23.63
9/30/2021996,200 shares $26.11 million -2.3%6.3%4.1 $26.21
9/15/20211,020,000 shares $27.31 million -1.0%6.5%4.2 $26.77
8/31/20211,030,000 shares $24.63 million +12.1%6.6%4.4 $23.91
8/13/2021918,600 shares $20.99 million +30.5%5.9%3.9 $22.85
$19 for a FULL YEAR of stock picks?! (Ad)

Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.

Watch the exclusive AI investor briefing >>>
7/30/2021704,000 shares $18.30 million -11.9%4.3%3.1 $26.00
7/15/2021798,800 shares $25.20 million -11.7%4.9%8.1 $31.55
6/30/2021904,100 shares $28.94 million -6.5%5.5%10.1 $32.01
6/15/2021966,400 shares $30.92 million -6.2%5.9%11.3 $32.00
5/28/20211,030,000 shares $35.63 million +13.8%6.3%12.5 $34.59
5/14/2021904,800 shares $30.31 million +6.6%5.5%12.2 $33.50
4/30/2021849,000 shares $32.97 million -1.7%5.5%12.9 $38.83
4/15/2021863,500 shares $31.95 million +6.4%5.6%12 $37.00
3/31/2021811,600 shares $28.35 million +13.9%5.3%11.1 $34.93
3/15/2021712,800 shares $26.14 million -8.3%4.8%9.1 $36.67
2/26/2021777,600 shares $26.31 million -12.4%5.2%10 $33.84
2/12/2021887,200 shares $31.97 million -4.8%6.0%11.5 $36.03
1/29/2021931,800 shares $30.39 million -4.3%6.3%12.3 $32.61
1/15/2021974,000 shares $36.64 million +5.6%6.5%11.6 $37.62
12/31/2020922,000 shares $29.04 million +4.0%6.2%9.9 $31.50
12/15/2020886,600 shares $29.78 million -10.2%6.0%9.4 $33.59
11/30/2020987,300 shares $35.53 million -2.3%6.6%10.6 $35.99
11/15/20201,010,000 shares $32.90 million +1.1%6.8%10.9 $32.57
10/30/2020998,600 shares $31.12 million -18.8%6.8%10.9 $31.16
10/15/20201,230,000 shares $44.72 million -30.5%8.4%14.4 $36.36

RLMD Short Interest - Frequently Asked Questions

What is Relmada Therapeutics' current short interest?

Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,030,000 shares of RLMD short. Learn More on Relmada Therapeutics' current short interest.

What is a good short interest ratio for Relmada Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 1.0. Learn More on Relmada Therapeutics's short interest ratio.

Is Relmada Therapeutics' short interest increasing or decreasing?

Relmada Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,030,000 shares, an increase of 44.0% from the previous total of 1,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Relmada Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Relmada Therapeutics: BeyondSpring Inc. (6.28%), PDS Biotechnology Co. (6.50%), Skye Bioscience, Inc. (18.48%), Acumen Pharmaceuticals, Inc. (3.95%), Exicure, Inc. (1.15%), Applied Therapeutics, Inc. (11.18%), Metagenomi, Inc. (13.59%), Context Therapeutics Inc. (4.20%), Achilles Therapeutics plc (1.26%), Verrica Pharmaceuticals Inc. (2.93%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Relmada Therapeutics stock?

Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. RLMD shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Relmada Therapeutics?

A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further.

How often is Relmada Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:RLMD) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners